Vident Investment Advisory’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,698
| Closed | -$596K | – | 1018 |
|
|
2023
Q2 | $596K | Buy |
2,698
+1,267
| +89% | +$280K | 0.02% | 630 |
|
|
2023
Q1 | $320K | Sell |
1,431
-540
| -27% | -$121K | 0.01% | 930 |
|
|
2022
Q4 | $548K | Sell |
1,971
-9,793
| -83% | -$2.72M | 0.02% | 678 |
|
|
2022
Q3 | $2.33M | Buy |
11,764
+10,829
| +1,158% | +$2.14M | 0.08% | 289 |
|
|
2022
Q2 | $214K | Buy |
+935
| New | +$214K | 0.01% | 1111 |
|
|
2018
Q3 | – | Sell |
-2,051
| Closed | -$232K | – | 1008 |
|
|
2018
Q2 | $232K | Buy |
2,051
+254
| +14% | +$28.7K | 0.01% | 852 |
|
|
2018
Q1 | $202K | Buy |
1,797
+150
| +9% | +$16.9K | 0.01% | 870 |
|
|
2017
Q4 | $244K | Buy |
+1,647
| New | +$244K | 0.01% | 735 |
|
|
2017
Q3 | – | Sell |
-17,949
| Closed | -$2.33M | – | 775 |
|
|
2017
Q2 | $2.33M | Buy |
17,949
+497
| +3% | +$64.5K | 0.19% | 202 |
|
|
2017
Q1 | $2.36M | Buy |
+17,452
| New | +$2.36M | 0.23% | 188 |
|
|
2015
Q4 | – | Sell |
-12,993
| Closed | -$1.71M | – | 827 |
|
|
2015
Q3 | $1.71M | Buy |
12,993
+2,645
| +26% | +$347K | 0.24% | 117 |
|
|
2015
Q2 | $1.8M | Buy |
10,348
+1,410
| +16% | +$245K | 0.24% | 108 |
|
|
2015
Q1 | $1.54M | Buy |
8,938
+4,108
| +85% | +$708K | 0.31% | 39 |
|
|
2014
Q4 | $625K | Buy |
+4,830
| New | +$625K | 0.21% | 155 |
|